Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

462 results
  1. ... 8 ] Fanconi anemia. Dyskeratosis congenita. Connexin variants. Chronic graft-versus-host disease. Epidermolysis bullosa. Xeroderma pigmentosum. Human papillomavirus infection. References Oksüzoğlu B, Yalçin S: Squamous cell carcinoma of ...
  2. ... Chimeric Antigen Receptor (CAR) T-Cell Therapy . Complications, Graft-Versus-Host Disease, and Late Effects after Pediatric Hematopoietic Stem Cell Transplant . References Matthay KK, Villablanca JG, Seeger RC, et al.: ...
  3. ... to state that a newer approach to preventing graft-versus-host disease (GVHD) includes administering posttransplant cyclophosphamide on days 3 and 4 after HSCT (cited Luznik et al. as reference 76). While it does not affect stem cells ...
  4. ... amounted to £6,226.29 per episode. No reference costs could be found for graft versus host disease. All costs associated with transplantation up to 100 ...
  5. ... amounted to £6,226.29 per episode. No reference costs could be found for graft versus host disease. All costs associated with transplantation up to 100 ...
  6. There are two main types of stem cells: embryonic stem cells and adult stem cells. Read about three ways stem cells differ from other cells in the body
  7. ... Before Transplant (National Marrow Donor Program) What is Graft-Versus-Host-Disease? ... (National Institutes of Health) Journal Articles References and abstracts from MEDLINE/PubMed (National Library of ...
  8. ... contact. Am J Med 1984; 76: 487-92. . References continued at foot of next column ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH ...
  9. ... capacity of the lung for carbon monoxide; GVHD = graft-versus-host disease; HSCT = hematopoietic stem cell transplant. ... Smith L, Glaser AW, Peckham D, et al.: ...
  10. NLM Digital Collections - Betibeglogene autotemcel for beta thalassemia : effectiveness and value : final evidence ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 19, 2022
    ... that it does not impose a risk of graft-versus-host disease or rejection. Despite ... to Table of Contents References w 10. 11. 12. 13. 14. 15. 16. ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last